Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$66.18 - $83.18 $1.79 Million - $2.25 Million
-27,009 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $65,887 - $79,550
-998 Reduced 3.56%
27,009 $2.15 Million
Q4 2021

Feb 04, 2022

SELL
$63.34 - $74.11 $32,303 - $37,796
-510 Reduced 1.79%
28,007 $2.06 Million
Q3 2021

Nov 12, 2021

SELL
$68.67 - $84.02 $56,721 - $69,400
-826 Reduced 2.81%
28,517 $1.96 Million
Q2 2021

Aug 13, 2021

SELL
$79.87 - $87.53 $9.96 Million - $10.9 Million
-124,738 Reduced 80.96%
29,343 $2.47 Million
Q1 2021

May 14, 2021

SELL
$76.02 - $100.5 $4.75 Million - $6.28 Million
-62,527 Reduced 28.87%
154,081 $12.5 Million
Q4 2020

Feb 16, 2021

SELL
$80.74 - $97.7 $1.08 Million - $1.31 Million
-13,404 Reduced 5.83%
216,608 $18.8 Million
Q3 2020

Nov 04, 2020

BUY
$85.07 - $109.69 $680,389 - $877,300
7,998 Added 3.6%
230,012 $20.6 Million
Q2 2020

Jul 31, 2020

SELL
$74.18 - $108.93 $2.85 Million - $4.19 Million
-38,477 Reduced 14.77%
222,014 $23.1 Million
Q1 2020

May 08, 2020

BUY
$63.18 - $85.97 $185,875 - $252,923
2,942 Added 1.14%
260,491 $19.1 Million
Q4 2019

Feb 11, 2020

SELL
$73.04 - $95.72 $499,812 - $655,011
-6,843 Reduced 2.59%
257,549 $22.5 Million
Q3 2019

Nov 01, 2019

BUY
$72.82 - $86.52 $15 Million - $17.9 Million
206,552 Added 357.11%
264,392 $19.6 Million
Q2 2019

Aug 13, 2019

SELL
$73.52 - $88.7 $2.34 Million - $2.83 Million
-31,884 Reduced 35.54%
57,840 $4.91 Million
Q1 2019

May 13, 2019

BUY
$63.56 - $88.17 $801,428 - $1.11 Million
12,609 Added 16.35%
89,724 $7.72 Million
Q4 2018

Feb 14, 2019

BUY
$58.5 - $69.94 $2.87 Million - $3.43 Million
48,975 Added 174.04%
77,115 $4.9 Million
Q3 2018

Nov 14, 2018

SELL
$61.75 - $74.23 $20,624 - $24,792
-334 Reduced 1.17%
28,140 $1.94 Million
Q2 2018

Aug 06, 2018

SELL
$60.85 - $83.98 $61,519 - $84,903
-1,011 Reduced 3.43%
28,474 $1.91 Million
Q1 2018

May 03, 2018

BUY
$83.06 - $100.98 $2.45 Million - $2.98 Million
29,485 New
29,485 $2.46 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.